Navigation Links
Advanced Cell Diagnostics Appoints Evangeline Gonzalez as Chief Commercial Officer
Date:1/25/2013

HAYWARD, Calif., Jan. 25, 2013 /PRNewswire/ -- Advanced Cell Diagnostics, Inc., a world leader in the field of in situ nucleic acid detection for life science research and clinical diagnostics, today announced the appointment of Evangeline Gonzalez to its executive leadership team as Chief Commercial Officer. In this role, Mrs. Gonzalez will lead the company's global commercialization efforts.  Mrs. Gonzalez will report directly to Advanced Cell Diagnostics CEO, Yuling Luo , Ph.D.

"It was the breakthrough technology and the multi-talented team that attracted me to Advanced Cell Diagnostics. I'm so excited to join the team to help grow the company to the next level," Mrs. Gonzalez said.

Mrs. Gonzalez has more than 17 years of commercialization experience in the biotechnology industry.  She joins Advanced Cell Diagnostics from Life Technologies (formerly Applied Biosystems and Invitrogen), a 3.7 billion dollar company, where she was most recently Chief Marketing Officer of the Life Sciences Division. In this role, she was responsible for facilitating growth, marketing and global market development strategy.  Previously she was Vice President of Market Development and Product Management for several businesses within Life Technologies including Protein Analysis, Sequencing and Molecular Biology Systems. In these roles, she was responsible for driving revenue growth for both existing products and commercializing new breakthrough technologies globally.

"Advanced Cell Diagnostics has achieved several important milestones over the last 3 months including closing a $12 million financing round, successfully introducing our automated RNAscope solution and expanding our commercial team," said Dr. Luo. "Evangeline's  proven track record of commercializing new technologies and her leadership skills are exactly what we need at this phase of our company's growth," Dr. Luo continued.

About Advanced Cell Diagnostics

Advanced Cell Diagnostics, Inc. (ACD) is a leader in the emerging field of molecular pathology, developing cell and tissue‐based diagnostic tests for personalized medicine. The company's products and services are based on its proprietary RNAscope® technology, the first multiplex chromogenic and fluorescent in situ hybridization platform capable of detecting and quantifying RNA biomarkers in situ at single‐molecule sensitivity. RNAscope assays are currently used by hundreds of customers, including all of the global top 10 pharmaceutical companies, world leading academic institutions and many cutting edge biotechnology companies to validate biomarkers for the management of cancer and other diseases.  ACD's industrial partnerships provide the foundation for ACD to develop companion diagnostic tests in conjunction with partners' targeted therapeutics. ACD also pursues internal programs to develop proprietary diagnostic tests in cancer management. Learn more about ACD and RNAscope technology at www.acdbio.com.

Contact:
Steve Chen , Ph.D.
Chief Operating Officer
(510) 259-9802
schen@acdbio.com


'/>"/>
SOURCE Advanced Cell Diagnostics, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. New Advanced High End Brix Refractometer
2. INRS acquires a groundbreaking advanced imaging infrastructure
3. GIN Introduces Advanced Robotics and Dispensing Technnology at SLAS 2013 in Orlando, FL
4. Nanonex Delivered Advanced Nanoimprint Tool NX-B200 to Swinburne University of Technology, Australia
5. University of Pennsylvania Purchases Nanonex Advanced Nanoimprint Tool NX-2600 BA
6. Advanced Polymer Trading to Exhibit at ArabPlast 2013 in Dubai
7. Dallas-Fort Worth Fertility Associates Celebrates First Birth in North Texas from Advanced Trophectoderm Biopsy Screening Technology
8. Advanced manufacturing venture highlights regions economic prospects
9. Advanced Cell Diagnostics Completes $12 Million Series B Financing
10. Highly efficient production of advanced biofuel by metabolically engineered microorganism
11. Merrimack Pharmaceuticals To Present Preliminary Clinical Data For Novel Therapies Targeting Molecular Pathways In Advanced Cancers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... ... June 23, 2016 , ... STACS DNA Inc., the ... at the Arkansas State Crime Laboratory, has joined STACS DNA as a Field Application ... team,” said Jocelyn Tremblay, President and COO of STACS DNA. “In further expanding our ...
(Date:6/23/2016)... , June 23, 2016 Apellis Pharmaceuticals, ... 1 clinical trials of its complement C3 inhibitor, ... and multiple ascending dose studies designed to assess ... of subcutaneous injection in healthy adult volunteers. ... either as a single dose (ranging from 45 ...
(Date:6/23/2016)... June 23, 2016 ... 2016;12(1):22-8 http://doi.org/10.17925/OHR.2016.12.01.22 Published recently ... peer-reviewed journal from touchONCOLOGY, Andrew D Zelenetz ... of cancer care is placing an increasing burden ... expensive biologic therapies. With the patents on many ...
(Date:6/23/2016)... ... 23, 2016 , ... ClinCapture, the only free validated electronic ... showcase its product’s latest features from June 26 to June 30, 2016 for ... Disrupting Clinical Trials in The Cloud during the conference. DIA (Drug Information ...
Breaking Biology Technology:
(Date:4/28/2016)... and BANGALORE, India , April 28, 2016 ... a product subsidiary of Infosys (NYSE: INFY ), ... a global partnership that will provide end customers ... mobile banking and payment services.      (Logo: ... innovation area for financial services, but it also plays a ...
(Date:4/26/2016)... and LONDON , April 26, ... of EdgeVerve Systems, a product subsidiary of Infosys ... announced a partnership to integrate the Onegini mobile ...      (Logo: http://photos.prnewswire.com/prnh/20151104/283829LOGO ) ... customers enhanced security to access and transact across ...
(Date:4/19/2016)... 2016 The new GEZE SecuLogic ... web-based "all-in-one" system solution for all door components. It ... the door interface with integration authorization management system, and ... The minimal dimensions of the access control and the ... installations offer considerable freedom of design with regard to ...
Breaking Biology News(10 mins):